In the present study, we found that knocking down STIM1 in EBV-positive NPC cells significantly dampened the ability of EGF to induce VEGF production, without affecting baseline VEGF expression (Figure 2A). This evidence concerns the gene VEGFA and nasopharyngeal carcinoma.